MOx 2.0 Case Study

Utilizing Transcriptomics to Diagnose Wiskott-Aldrich Syndrome

Download Our Free CentoXome MOx 2.0 Case Study Today!

A success story from our multiomic Whole Exome Sequencing (WES) testing solution – CentoXome MOx 2.0 – now including Transcriptomics.

Check out our case study to see how we were able to diagnose this young patient. By using RNA analysis for splicing variants, we were able to give definite answers to the young patients' family.

By clicking “Download now” I agree that CENTOGENE will get in touch via email on latest news regarding our clinical diagnostics and scientific developments on rare diseases, including but not limited to upcoming events and commercial offers. I can withdraw my consent at any time for the future by clicking the “Unsubscribe” button in the emails or by contacting CENTOGENE directly.

Why Choose CentoXome MOx 2.0

Integrated genomic and biochemical testing facilitates the decision on the pathogenicity of clinical variants leading to higher diagnostic yield

Biochemical testing allows for orthogonal confirmation of disease – accelerating the path to a diagnosis by avoiding stepwise testing​

Includes RNA analysis for splicing variants, followed by available biomarker and enzyme confirmatory testing